A 2025 randomized trial found PEMF therapy for pain relief reduced pain scores by 36% and helped 55% of patients reduce or stop pain medications. This study highlights PEMF as a safe, evidence-based, noninvasive therapy for managing joint and soft tissue pain.
Clinical Evidence of PEMF Therapy for Pain Relief
Chronic joint and soft tissue pain is one of the most common reasons people seek care, affecting mobility, independence, and overall quality of life. Standard treatments often rely on medications or invasive procedures, each carrying limitations and risks.
A 2025 multi-center randomized clinical trial involving 275 patients found that pulsed electromagnetic field (PEMF) therapy for pain relief reduced pain scores by 36% in just 60 days, compared with only 10% improvement from standard care alone. Even more striking, 55% of PEMF patients reduced or discontinued pain medication, versus 12% in the standard care group.
These findings suggest PEMF could reshape how chronic pain is managed, providing a safe, noninvasive, and drug-free option for both patients and providers.
Study Overview
Title: Evaluating Noninvasive Pulsed Electromagnetic Field Therapy for Joint and Soft Tissue Pain Management: A Prospective, Multi-center, Randomized Clinical Trial
Authors: Zampogna et al.
Journal: Pain and Therapy (2025)
Design: Prospective, randomized, multi-center clinical trial
Participants: 275 patients with joint or soft tissue pain
Comparison: Standard of Care (SOC) vs. SOC + PEMF therapy
Duration: 60 days
Outcome Measures: Pain scores (NRS), medication use, quality of life measures
Read the full study on Springer
Key Findings
Pain Reduction
Patients using PEMF alongside standard care showed a 36% reduction in pain scores at 60 days.
By comparison, the standard care group improved by only 10%.
Medication Use
55% of PEMF patients reduced or discontinued analgesic use, compared with 12% in the SOC group.
This suggests PEMF may help lower reliance on pain medications, including NSAIDs and opioids.
Function and Quality of Life
PEMF patients reported improvements in mobility and daily activity scores.
No major adverse events were associated with the therapy, reinforcing its safety profile.
Implications for Pain Management
Pain management has long leaned heavily on pharmaceuticals or invasive interventions. This trial adds to growing evidence that PEMF therapy offers a safe, noninvasive, and drug-free alternative.
For patients, it means fewer side effects and greater independence. For clinicians and wellness professionals, it signals an opportunity to integrate a therapy that aligns with modern demands for safer, evidence-based, and holistic approaches.
From Research to Real-World Application: BH Labs
At BH Labs, we empower health and wellness professionals with cutting-edge biohacking solutions designed to enhance performance, accelerate recovery, and support healthy longevity.
As a leader in wellness technology, we specialize in seamlessly integrating evidence-based modalities—including hyperbaric oxygen therapy (HBOT), red light therapy, PEMF, infrared saunas, and compression-based lymphatic therapy—into existing practices. Our turnkey approach enables clinics, spas, and fitness facilities to deliver high-value treatments without added complexity, boosting client outcomes while driving new revenue streams.
From pain relief and recovery to performance optimization and cellular health, BH Labs provides the tools, training, and ongoing support needed to help forward-thinking professionals stay ahead in a rapidly evolving wellness industry.
Discover how BH Labs can help you future-proof your practice with science-backed innovations at www.bh-labs.com.
—
BH Labs Recovery Pods package these clinically-studied modalities into one turnkey system — starting at $49K.
Talk to Us